PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation (Q92518269)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

title

PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

stem cell transplantation

30 April 2020

main subject

1 reference

based on heuristic

inferred from title

diffuse large B-cell lymphoma

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

10

Ann S LaCasce

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

22

Jerome Ritz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

24

Margaret A Shipp

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

author name string

Matthew J Frigault

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

Philippe Armand

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

Robert A Redd

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

Erin Jeter

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

Reid W Merryman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

Kimberly C Coleman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

Alex F Herrera

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

Parastoo Dahi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

David C Fisher

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

Samuel Y Ng

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

Oreife O Odejide

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

Arnold S Freedman

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

Austin I Kim

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

Jennifer L Crombie

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

Caron A Jacobson

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

Eric D Jacobsen

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

Jeffrey L Wong

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

Jad Bsat

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

Sanjay S Patel

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

Scott J Rodig

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

Yi-Bin Chen

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

Robin M Joyce

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

publication date

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

page(s)

122-126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation

30 April 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6960482

PD-L1 and tumor-associated macrophages in de novo DLBCL

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6960482

Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6960482

Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin Lymphomas

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6960482

Cancer Immunotherapy and the Immune Response in Follicular Lymphoma.

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6960482

Checkpoint blockade in Hodgkin and non-Hodgkin lymphoma

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6960482

PD-1 expression and clinical PD-1 blockade in B-cell lymphomas

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6960482

Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6960482

Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma.

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6960482

Using Model-Based "Learn and Confirm" to Reveal the Pharmacokinetics-Pharmacodynamics Relationship of Pembrolizumab in the KEYNOTE-001 Trial

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6960482

Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6960482

Phase I Study of Pembrolizumab (MK-3475; Anti-PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors.

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6960482

Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6960482

PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6960482

Prognostic factors for patients with diffuse large B cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emission tomography era

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6960482

Characteristics and outcomes after autologous stem cell transplant for patients with relapsed or refractory diffuse large B-cell lymphoma who failed initial rituximab, cyclophosphamide, adriamycin, vincristine, and prednisone therapy compared to pat

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6960482

The International Harmonization Project for response criteria in lymphoma clinical trials

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6960482

10.1182/BLOODADVANCES.2019500784

11 February 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31917843 AND SRC:MED&resulttype=core&format=json

30 April 2020

PubMed publication ID

31917843

1 reference